Literature DB >> 17069807

Phospholipase D protects ECV304 cells against TNFalpha-induced apoptosis.

Helene Birbes1, Caroline Zeiller, Hiba Komati, Georges Némoz, Michel Lagarde, Annie-France Prigent.   

Abstract

Tumor necrosis factor alpha (TNFalpha), a pleiotropic cytokine, activates both apoptotic and pro-survival signals depending on the cell model. Using ECV304 cells, which can be made TNFalpha-sensitive by cycloheximide (CHX) co-treatment, we evaluated the potential roles of ceramide and phospholipase D (PLD) in TNFalpha-induced apoptosis. TNFalpha/CHX induced a robust increase in ceramide levels after 16 h of treatment when cell death was maximal. PLD activity was increased at early time point (1h) whereas both PLD activity and PLD1 protein were strongly decreased after 24h. TNFalpha/CHX-induced cell death was significantly lowered by exogenous bacterial PLD and phoshatidic acid, and in cells overexpressing PLD1. Conversely, cells depleted in PLD proteins by small interference RNA (siRNA) treatment exhibited higher susceptibility to apoptosis. These results show that PLD exerts a protective role against TNFalpha-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17069807     DOI: 10.1016/j.febslet.2006.10.026

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

Review 1.  Integration of cytokine biology and lipid metabolism in stroke.

Authors:  Rao Muralikrishna Adibhatla; Robert Dempsy; James Franklin Hatcher
Journal:  Front Biosci       Date:  2008-01-01

2.  ADP-ribosylation factor as a novel target for corneal neovascularization regression.

Authors:  Chunyan Dai; Gaoqin Liu; Longbiao Li; Yanhui Xiao; Xueguang Zhang; Peirong Lu
Journal:  Mol Vis       Date:  2012-12-12       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.